Healthcare AI firm annalise.ai has partnered with Fujifilm Australia for the distribution of its decision support solutions for portable and stationary chest x-ray machines.
Annalise CXR Edge is a software as a medical device that assists clinicians and radiologists in interpreting chest x-rays. According to the company, its AI algorithm identifies and notifies suspected findings in under 10...
Women’s health startup Inne raises $10M
Berlin-based healthtech startup Inne has raised an additional $10 million (€9.3M) in funding led by DSM Venturing.
Borski Fund and Calm Storm Ventures also participated in the round, along with angels Taavet Hinrikus (Wise), Dr Fiona Pathiraja and Rolf Schromgens (Trivago).
Inne will use the investment to continue to develop its mini lab and platform to...
Researchers from Chulalongkorn University, a public university in Thailand, have created an AI-based system for detecting gastrointestinal disorders.
WHAT IT DOES
DeepGI (Deep Technology for Gastrointestinal Tracts) spots abnormal tissues indicative of early colonic neoplasm, such as polyps, in the colon with over 90% accuracy, according to Dr Peerapon Vateekul, a member of the research team from...
Oxford Drug Design raises £2.2M to develop AI-based drug discovery programme
Biotechnology firm Oxford Drug Design Limited (ODD) has raised £2.2M in funding from existing investors ACF Investors, o2h Ventures, Meltwind Advisory, several returning angels and new investors and the US-based R42 Group.
The Oxford University spinout has created an artificial intelligence (AI) AI proprietary platform...
Artificial intelligence deep learning models can be trained to predict self-reported race from imaging results, raising concerns about worsening health disparities, according to a study published in The Lancet Digital Health.
Researchers found models could detect race from different types of chest imaging results, including X-rays, CT scans and mammograms. The ability couldn't be traced back to...
Australia-listed medtech firm Artrya has disclosed that its subsidiary in the United States has signed a clinical partnership with Alabama-based Huntsville Heart Center.
According to a media release, an initial agreement between the companies involves a study to determine the efficacy of Artrya's AI technology for diagnosing coronary heart disease.
WHY IT MATTERS
The Artrya Salix is an AI-powered...
Fujitsu has teamed up with Southern Tohoku General Hospital in Fukushima, Japan for a joint research project to come up with an AI solution that detects pancreatic cancer from CT scans at an early stage.
According to a press release, the project will use Fujitsu's AI tech, which has been trained with over 300 anonymised CT images of pancreatic cancer patients at Southern Tohoku General Hospital,...
AI tool receives UK regulatory approval to support urgent skin cancer cases
Artificial intelligence (AI) dermatology firm Skin Analytics has received Class IIA status under the UK Medical Device Regulations 2002 for its device, DERM.
DERM uses machine learning to support clinicians in recognising the most common malignant, pre-malignant and benign skin lesions.
James Hamlyn, quality assurance...
Japanese medtech startup Ubie has launched its AI symptom checker in the United States.
The web-based Ubie AI Symptom Checker generates relevant questions about a user's symptoms from around 3,500 question data types based on its database of 50,000 medical papers.
After answering about 20 questions, users can discover related diseases and more detailed information about their possible conditions...
Fujifilm Corporation has developed AI technology that can predict whether patients with mild cognitive impairment will progress to Alzheimer's disease within two years.
According to a press statement, the AI Technology for AD Progression Prediction has been found to have high generalisability, predicting patients who would progress to AD with high accuracy, even for subjects from different...